The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversies.
about
The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of combined fludarabi ...... nt evidence and controversies.
@en
The role of combined fludarabi ...... nt evidence and controversies.
@nl
type
label
The role of combined fludarabi ...... nt evidence and controversies.
@en
The role of combined fludarabi ...... nt evidence and controversies.
@nl
prefLabel
The role of combined fludarabi ...... nt evidence and controversies.
@en
The role of combined fludarabi ...... nt evidence and controversies.
@nl
P2860
P356
P1476
The role of combined fludarabi ...... nt evidence and controversies.
@en
P2093
Alan P Skarbnik
P2860
P304
P356
10.1177/2040620716681749
P577
2016-12-01T00:00:00Z